SEC Form 4 insider trading filings tracked in real time from EDGAR

Burrows Scott L — Chief Financial Officer

Insider trading activity for Burrows Scott L sourced from SEC EDGAR Form 4 filings.

Overview

  • Title: Chief Financial Officer
  • Company: Spyre Therapeutics, Inc.
  • Total insider trades: 33
  • Total buy volume: $109K
  • Total sell volume: $8.3M
  • Last trade: Oct 2, 2026

Recent Trades

DateInsiderTicker / Company TypeSharesValue
Oct 1, 2026 Burrows Scott L SYRE Spyre Therapeutics, Inc. OTHER 7,500 $0
Sep 30, 2026 Burrows Scott L SYRE Spyre Therapeutics, Inc. OTHER 17,500 $0
Oct 1, 2026 Burrows Scott L SYRE Spyre Therapeutics, Inc. SELL 229 $21K
Oct 1, 2026 Burrows Scott L SYRE Spyre Therapeutics, Inc. SELL 3,071 $285K
Oct 1, 2026 Burrows Scott L SYRE Spyre Therapeutics, Inc. SELL 2,100 $193K
Oct 1, 2026 Burrows Scott L SYRE Spyre Therapeutics, Inc. SELL 1,500 $135K
Oct 1, 2026 Burrows Scott L SYRE Spyre Therapeutics, Inc. SELL 600 $53K
Oct 1, 2026 Burrows Scott L SYRE Spyre Therapeutics, Inc. OTHER 7,500 $109K
Sep 30, 2026 Burrows Scott L SYRE Spyre Therapeutics, Inc. SELL 17,500 $1.6M
Sep 30, 2026 Burrows Scott L SYRE Spyre Therapeutics, Inc. OTHER 17,500 $254K
Sep 2, 2026 Burrows Scott L SSYRE SSYRE SELL 18,232 $1.6M
Sep 1, 2026 Burrows Scott L SSYRE SSYRE SELL 7,500 $655K
Sep 1, 2026 Burrows Scott L SSYRE SSYRE BUY 7,500 $109K
Jul 1, 2026 Burrows Scott L SYRE Spyre Therapeutics, Inc. OTHER 7,500 N/A
Jul 1, 2026 Burrows Scott L SYRE Spyre Therapeutics, Inc. SELL 1,725 $152K
Jul 1, 2026 Burrows Scott L SYRE Spyre Therapeutics, Inc. SELL 5,775 $506K
Jul 1, 2026 Burrows Scott L SYRE Spyre Therapeutics, Inc. OTHER 7,500 $109K
Jun 25, 2026 Burrows Scott L SYRE Spyre Therapeutics, Inc. OTHER 15,000 N/A
Jun 25, 2026 Burrows Scott L SYRE Spyre Therapeutics, Inc. SELL 10,000 $871K
Jun 25, 2026 Burrows Scott L SYRE Spyre Therapeutics, Inc. SELL 5,000 $436K

← All executives · Full trades feed